All articles tagged with #us food and drug administration
The Supreme Court issued a temporary order allowing patients to continue receiving the abortion pill mifepristone by mail for one week as it weighs emergency appeals from drugmakers challenging a lower-court ruling that required in-person pickup.
A federal appeals court temporarily reinstated the rule that abortion pills must be picked up in person, blocking access via mail and telehealth. The decision, tied to Louisiana’s suit against the FDA, is a win for antiabortion advocates and will affect access in states with bans while manufacturers seek to pause or challenge the ruling.
The Washington Post’s The Post's View argues that RFK Jr.’s push to loosen peptide regulations contradicts FDA scientists’ warnings that many peptides are ineffective and potentially dangerous, accusing him of hypocrisy for promoting an experimental wellness trend while doubting vaccines.
Vinay Prasad, the FDA’s controversial head of vaccines and complex therapies, will step down at the end of April after a tenure marked by divisive drug and vaccine decisions and a push to tighten vaccine approvals; his tenure included a prior brief removal and quick reinstatement in 2025.
An oncologist notes that while most dietary supplements aren’t harmful, some—particularly antioxidants for immunocompromised patients—should be used with caution. There’s no clear evidence that supplements prevent cancer, and their use can raise safety and interaction concerns with cancer therapies; patients should discuss any supplement plan with their clinician and be mindful of regulatory and safety considerations.